Heptares Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Heptares Therapeutics M&A Summary

Heptares Therapeutics has acquired 1 company of its own.

Heptares Therapeutics’ largest acquisition to date was in 2016, when it acquired G7 Therapeutics AG for $12M. The Company’s most targeted sectors include life science (100%).

Heptares Therapeutics Ownership

Who owns Heptares Therapeutics?

Heptares Therapeutics is owned by Sosei Group. It was acquired on February 22, 2015.

Heptares Therapeutics Business Overview

Where is Heptares Therapeutics headquartered?

Heptares Therapeutics is headquartered in Welwyn Garden City, United Kingdom.

What sector is Heptares Therapeutics in?

Heptares Therapeutics is a life science company.

When was Heptares Therapeutics founded?

Heptares Therapeutics was founded in 2007.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Heptares Therapeutics Ltd.

BioPark Broadwater Road,
Welwyn Garden City, AL7 3AX
United Kingdom,
+44 17 0735 8628
www.heptares.com

Heptares Therapeutics Ltd. is a clinical-stage company creating transformative medicines targeting G protein-coupled receptors (GPCRs), a superfamily of 375 receptors linked to a wide range of human diseases. Its proprietary structure-based drug design technology enables us to engineer drugs for highly validated, yet historically undruggable or challenging, GPCRs.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $12M $12M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
G7 Therapeutics AG 2016-11-30 12M CHF Add-on Acquisition
Schlieren, Switzerland · www.g7therapeutics.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 12M (100%) - -
Total 1 $12M - -

By Geo

State/Country Buy Value Sell Value
Switzerland 1 12M - -
Total 1 $12M - -

Deal Values

buy # Total
< $100M 1 $12M
TOTAL $12M
Largest G7 Therapeutics AG
$12M (2016-11-30)

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Heptares Therapeutics

Life Science Companies , United Kingdom Companies